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ABSTRACT
Durian or scientifically known as Durio zibethinus is one of the most well-known seasonal fruits in the Southeast Asia 
region. However, its safe consumption in individuals with hypertension is still controversial. This study was conducted 
to investigate the effect of durian on blood pressure of spontaneously hypertensive rat model. Four groups of rats (n=5) 
were fed with either a low dose durian (26 g/kg), a high dose durian (52 g/kg), sugar solution (8 mL/kg) which has 
similar sugar composition in the durian as placebo control, and distilled water as vehicle control (8 mL/kg) for 14 days. 
The durian doses for rats were obtained by converting from human doses. Baseline reading of blood pressure and heart 
rate were recorded before the first oral administration of durian. The blood pressure and heart rate were also measured 
1 h after the durian oral administration on day 1, 3, 7 and 14 of the experiment. In conclusion, durian fruit possessed 
an acute effect on the blood pressure of hypertensive rats but heart rate was unaffected. High dose administration of 
durian led to significant elevation of blood pressure after 1 h of consumption. Meanwhile, low dose of durian (26 g/kg) 
caused an insignificant reduction in systolic and diastolic blood pressure. Tolerance to the durian fruit was observed after 
three to seven days of the oral administration and low dose consumption of durian fruit was safe in the hypertensive rat. 
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ABSTRAK
Durian atau nama saintifiknya Durio zibethinus adalah sejenis buah bermusim yang paling terkenal di rantau Asia 
Tenggara. Walau bagaimanapun, penggunaannya yang selamat pada individu berpenyakit hipertensi masih kontroversi. 
Kajian ini dijalankan untuk mengkaji kesan durian terhadap tekanan darah pada model tikus berhipertensi spontan. 
Empat kumpulan tikus (n=5) diberi sama ada dos durian yang rendah (26 g/kg), dos durian tinggi (52 g/kg), larutan gula 
(8 mL/kg) yang menyamai komposisi gula dalam durian sebagai kawalan plasebo atau air minuman sebagai kawalan 
negatif (8 mL/kg) selama 14 hari. Dos durian untuk tikus diperoleh melalui pertukaran daripada dos manusia. Bacaan 
asas tekanan darah dan kadar denyutan jantung direkodkan sebelum pemberian oral dos pertama durian. Tekanan 
darah dan kadar denyutan jantung juga diukur satu jam selepas pemberian oral dos durian pada hari ke 1, 3, 7 dan 14 
eksperimen. Kesimpulannya, buah durian mempunyai kesan akut pada tekanan darah tikus berhipertensi tetapi kadar 
denyutan jantung tidak terjejas. Pengambilan dos durian yang tinggi menunjukkan peningkatan ketara tekanan darah 
selepas satu jam. Sementara itu, pengambilan dos durian yang rendah (26 g/kg) menyebabkan penurunan tekanan darah 
sistolik dan diastolik yang tidak ketara. Toleransi terhadap buah durian diperhatikan selepas tiga hingga tujuh hari 
pemberian oral dan pengambilan dos buah durian yang rendah adalah selamat pada tikus berhipertensi.
Kata kunci: Durian; hipertensi; kadar denyutan jantung; tekanan darah; tikus berhipertensi spontan
INTRODUCTION
Durian fruit or Durio zibethinus Murray is a one of 
the famous seasonal fruits in the Southeast Asia. It is a 
member of Bombacaceae family and widely known as the 
‘king of fruits’. Besides, durian fruit is rich in nutritional 
values such as antioxidants (vitamin E and beta-carotene), 
minerals (potassium, magnesium, calcium and sodium), 
trace elements (iron, zinc, copper and manganese), sulphur 
compounds and sugars (sucrose, fructose and glucose) 
(Voon et al. 2007). 
 In addition, durian plant is also used traditionally to 
treat diseases such as fever, jaundice and infertility (Ansari 
2016; Sah et al. 2014). However, despite of its nutraceutical 
and medicinal values, durian is believed to be a  ‘heaty’ 
food (Ariff & Beng 2006). Durian fruit is also avoided 
by pregnant women in Indonesia as they believe that 
its consumption could lead to miscarriage (Hartini et al. 
2005). Moreover, people with hypertension are concerned 
that eating durian might increase their blood pressure (BP) 
(Ariff & Beng 2006). 
 There is a limited study carried out about the 
relationship of durian on BP. A previous study on normal 
Sprague Dawley rats suggested that no significant 
differences in BP of normal rats after being fed with durian 
(Chua et al. 2008). Recently, research carried out by 
Kumolosasi et al. (2016) reported that there was also no 
significant increase in BP in healthy human subjects after 
durian consumption, but significant increase in heart rate 
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was observed. To the best of authors’ knowledge, the effect 
of durian on hypertensive subjects has not been studied. 
This study was carried out to investigate the effect of durian 




CODATM tail-cuff equipment (Kent Scientific, USA), 
weighing machine (A & D, Japan), refrigerator (Sharp), 
3 mL syringe (Terumo), 5 mL syringe (Terumo), amber 
bottles, filter, oral gavage, rats’ cages, water bottles, tissue 
paper, masks and gloves.
FOOD MATERIALS
Durian flesh (clone D24) was purchased from a local 
market in Kuala Lumpur, Malaysia, distilled water, glucose 
powder, crystalline fructose and sucrose. 
ANIMALS
Female SHR with weight ranging from 150 - 200 g were 
purchased from the Animal Experimental Unit (AEU) 
of University Malaya. The rats were kept randomly 
in different plastic cages with three rats in each cage. 
Then, the rats were adapted at a well-ventilated animal 
laboratory under 26 ± 1°C with standard 12-h/12-h light/
dark cycle for at least one week before the experiment 
was carried out. They were fed with standard pellet diet 
and water ad libitum. The animals were maintained under 
standard conditions and procedures were approved by the 
UKM Animal Ethics Committee with an approval number 
FF/2016/ENDANG/18-MAY/753-MAY-2016-JAN-2017.
PREPARATION OF THE TEST SAMPLES AND CONTROLS
Test samples consists of two different doses of durian flesh 
(26 g/kg body weight) for low dose and (52 g/kg body 
weight) for high dose. The durian flesh was separated 
from their seeds and passed through a tea strainer to 
remove the fibre. The texture was soft enough to allow oral 
administration using a size 15 oral gavage needle. Both low 
and high doses of the durian were based on conversion from 
human dose of previous study carried out by Kumolosasi 
et al. (2016) to the rat dose. The dose conversion was 
calculated according to Laurence and Bacharach (1964). 
Placebo control used in this experiment was sugar solution 
consisting of sucrose, fructose and glucose at a ratio of (8 
: 1 : 1), respectively, to match the sugar composition in 
250 g durian flesh while the vehicle control group of rats 
received only distilled water. 
BP AND HEART RATE MEASUREMENT
Preliminary study was carried out to determine the 
optimum time for BP measurement after oral administration 
of durian. Three rats per group were used and fed with high 
dose of durian (52 g/kg). Following the oral administration, 
the BP of each rat was recorded at time intervals of 0.5, 
1, 2, 3 and 4 h. The peak BP was found at 1 h after durian 
administration. 
 The actual study was carried out using five rats 
per group. BP of the rats were recorded using CODATM 
Non-Invasive Blood Pressure System prior to oral 
administration of durian. The measurement provided 
the baseline parameter for the BP of the rats. The BP 
measurements were then repeated after 1 h (peak BP from 
the preliminary study) of the oral administration on day 
1, day 3, day 7 and day 14 of the experiment. Five stable 
readings were recorded. The average values of the heart 
rate, SBP and DBP were calculated. 
STATISTICAL ANALYSIS
The parameters measured in this experiment were heart 
rate, systolic and diastolic blood pressure before and after 
oral administration of durian. Data were analyzed using 
PRISM software version 5. The differences between the 
groups were investigated using a one-way analysis of 
variance (ANOVA), followed by Tukey post hoc test. The 
differences were considered significant if p<0.05. 
RESULT AND DISCUSSION
Figure 1 shows the mean systolic blood pressure (SBP), 
diastolic blood pressure (DBP) and heart rate (HR) of SHR 
within 4 h after oral administration of 52 g/kg durian. The 
mean SBP and DBP increased significantly (p<0.05) after 
1 h of the durian administration. After that, the mean SBP 
and DBP readings decreased slowly to their baseline levels. 
It was observed that the mean heart rate increased after the 
oral administration and reached its peak after one hour, but 
the increment is not significant. The mean heart rate also 
decreased slowly and reached its baseline level within 4 h 
post oral administration of durian. 
Value expressed as mean ± standard error mean (SEM); n=3; BSL, Baseline reading 
(before durian administration); SYS, Systolic blood pressure; DIAS, Diastolic 
blood pressure; HR, Heart rate. *Statistically significant difference (p<0.05) 
compared with BSL
FIGURE 1. Blood pressure (mmHg) and heart rate (bpm) of SHR 
within 4 h after oral administration of 52 g/kg durian
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 The preliminary study indicated that administration of 
52 g/kg durian fruit possess an effect on the BP of SHRs, 
where it can further increase the systolic and diastolic BP. 
In SHR, the elevated BP is initially caused by an increased 
in central sympathetic outflow, followed by enhanced 
total peripheral resistance (TPR) with a normal cardiac 
output (CO) and decreased in permeability of glomerular 
membranes (Badyal et al. 2003). Thus, durian may cause 
rise in the BP by altering those factors, but this mechanism 
of action has not been investigated. 
 The peak time of the effect observed was 1 h and 
it was suggested that the concentration of the bioactive 
compounds in durian fruit that cause the SBP and DBP to 
rise was the highest in the rats’ blood after 1 h of durian 
consumption. 
 Subsequently, the mean SBP and DBP readings 
decreased slowly to their baseline level after 1 h. However, 
different findings for the heart rate were observed, in which 
the increment after 1 h of feeding with 52 g/kg durian was 
not significant. This finding differs from previous study 
that reported the consumption of high dose durian (500 
g) by healthy human subject lead to a significant increase 
in heart rate after 0.5 to 2 h (Kumolosasi et al. 2016). The 
finding in the rats suggests that the consumption of high 
dose durian by SHR only affected their SBP and DBP, but 
not their heart rate. 
 Previous research reported that BP and heart rate 
are controlled by one central mechanism, most likely 
the suprachiasmatic nucleus in the hypothalamus, but 
independent control of those parameter are also possible 
(Janssen et al. 1994; Saleh & Winget 1977; Sano et al. 
1995). In addition, blood pressure is the product of the 
cardiac output and total peripheral resistance, thus any 
alteration to the BP can be done by modifying one of those 
factors (Opie & Kaplan 2012). 
EFFECT OF DIFFERENT DOSES OF DURIAN 
ON BLOOD PRESSURE
Figure 2(A) and 2(B) shows the effect of different doses 
of durian on SBP throughout 14 days of the study. Figure 
2(A) shows that after the first dose of oral administration, 
the SBP of the low dose group decreased compared to the 
vehicle control group, but the reduction is not significant. 
The SBP of high dose group increased compared to the 
vehicle control group. However, the increment was also 
not significant. Interestingly, the mean SBP of the low 
dose and high dose groups was significant difference 
(p<0.01, n=5) at day1 and with p-value < 0.05, n=5 at 
day 3, respectively. Towards the 14th day of the oral 
administration, high dose, low dose and placebo control 
group showed an increase in mean SBP, but the values 
were not significant compared to vehicle control group. 
Figure 2(B) illustrates the mean change in SBP. The high 
dose group possess positive mean change (increase) in the 
SBP, meanwhile the other three groups showed negative 
change (decrease). On day 1, the change in SBP of high 
dose group was significant compared to vehicle control 
(p<0.05, n=5), placebo control (p<0.01, n=5) and low 
dose (p<0.01, n=5) groups, respectively. Then on the day 
3 to day 14 no changes were significant.
 The effect of different doses of durian on the DBP is 
illustrated in Figure 3(A) and 3(B). Figure 3(A) shows that 
on day 1, the high dose group of durian (52 g/kg) produced 
a significant increase in DBP compared to placebo control 
group and low dose group with (p<0.05, n=5) for both. The 
change of DBP of high dose group on day 1 was significant 
higher (p<0.01, n=5) compared with VC, (p<0.01, n=5) 
compared with LD and (p<0.01, n=5) compared with PC, 
respectively. The profile was similar with SBP where on the 
day 3 to day 14 no more significant changes were observed 
(Figure 3(B)).
Value expressed as mean ± standard error mean (SEM); n = 5; VC, Vehicle control; PC, Placebo control; LD, Low dose (26 g/kg); HD, High dose (52 g/
kg). *Statistically significant difference (p<0.05) when compared with VC. ++ (p<0.01) compared with PC. # Statistically significant difference (p<0.05) 
and ## (p<0.01) compared with LD, respectively 
FIGURE 2. (A) Systolic blood pressure of SHR throughout 14 days of experiment and (B) Change in systolic blood 
pressure of SHR throughout 14 days of experiment
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 Different doses of durian had shown to affect BP 
differently. The opposite effect on the SBP might be related 
to the different concentration of bioactive compounds that 
caused alteration in the mean SBP. This finding suggests 
that the low dose of durian (26 g/kg) contain insufficient 
amount of bioactive compounds that can lead to mean SBP 
elevation. 
 The significant difference in mean SBP between the 
low dose and high dose group of durian only persisted on 
day 1 until the third day of the experiment. Meanwhile, the 
mean DBP between the low and high dose group showed 
a significant difference only after the first day of oral 
administration. This suggests that durian fruit showed an 
acute effect on the SBP and DBP of SHRs. Repeated doses 
of durian showed reduced response on the SBP may due 
to tolerance. Tolerance can be developed by different 
mechanism including the change in receptor, physiological 
adaptation or increased in metabolic degradation of the 
drugs or bioactive compounds (Rang et al. 2011). 
 The high dose group showed a considerably persistent 
elevation in SBP and DBP throughout the period of study. 
Even though the high dose group are significant only at 
day 1 and 3 for SBP and at day 1 for DBP then followed 
by insignificant difference compared to vehicle control, 
this finding suggests that durian need to be taken in 
considerable amount by hypertensive subjects as it can 
cause an increase in SBP and DBP which might increase the 
risk of other cardiovascular events (Sokolow et al. 1966). 
Another study done by Chua et al. (2008) also reported 
that the blood pressure of Sprague Dawley rats within 
5 h interval after oral administration of 16 g/kg durian 
shows no significant difference from the baseline level. 
However, the doses used in their study is much lower 
compared to those in this study which were 26 and 52 g/kg, 
moreover the rats used in their study were not hypertensive 
rats which might be the reason to the differences in our 
findings.
 Previous study carried out by Kumolosasi et al. (2016) 
reported that there was no alteration in SBP and DBP in 
healthy human after the consumption of low or high dose 
of durian. However, in this study, there is a persistent 
alteration in the SBP and DBP in SHRs throughout the 
experiment. BP measurement of normal rats also showed 
insignificant difference within 5 h post oral administration 
of 16 g/kg durian (Chua et al. 2008). This suggests that 
durian fruit affected the BP of healthy humans or normal 
rats and hypertensive rats (pathological condition) 
differently. 
 Rats in the placebo control group received sugar 
solution with similar sugar composition with the 26 g/
kg durian (Voon et al. 2007). Since the placebo control 
contained the same amount of sugar as in the low dose of 
durian, this suggests that the increment in mean SBP by 
both groups after seventh day of oral administration was 
caused by the repeated consumption of sugar-containing 
food (sucrose, fructose and glucose). This is consistent 
with the result from previous research that reported 
fructose may increase BP and promote the accumulation of 
visceral adiposity, dyslipidemia and ectopic fat deposition 
because of increased hepatic de novo lipogenesis 
(Stanhope et al. 2009). Besides, diet which contained high 
amount of sugar might have triggered a rise in BP which 
is about twice as seen in a high salt diet (Dinicolantonio 
& O’keefe 2016). 
EFFECT OF DIFFERENT DOSES OF DURIAN 
ON HEART RATE (HR)
Figure 4(A) and 4(B) presents the overall effect of 
both doses of durian groups on heart rate. Figure 4(A) 
shows that the placebo control and high dose groups 
contributed to the rise in heart rate while low dose and 
vehicle control groups showed reducing effect in heart 
rate after the first administration. However, all of the 
values are statistically insignificant. Meanwhile, there 
Value expressed as mean ± standard error mean (SEM); n = 5. LD, Low dose (26 g/kg); HD, High dose (52 g/kg); VC, Vehicle control; 
PC, Placebo control. ** Statistically significant difference (p<0.01) compared with VC. #Statistically significant difference (p<0.05) and 
## (p<0.01) when compared with LD, respectively. + (p<0.05) and ++ (p< 0.01) when compared with PC, respectively 
FIGURE 3. (A) Diastolic blood pressure of SHR throughout 14 days of experiment and (B) Change in 
diastolic blood pressure of SHR throughout 14 days of experiment 
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was a significant difference between placebo control 
group and vehicle control group on the third day of the 
experiment (p<0.05, n=5). As shown in Figure 4(B), the 
placebo control and high dose groups showed an increase 
in the mean HR on day 1 but the low dose group showed 
reduction in HR. Nonetheless, those differences were not 
significant when compared to vehicle control. The mean 
HR for the placebo control on day 3 was shown to increase 
following the oral administration. At the same time, the 
mean HR of both low and high doses of durian showed 
reduction but no significant difference was observed. 
The pattern of the mean change of HR was reduced on 
day 7 onwards. 
 Dinicolantonio and O’Keefe (2016) reported that 
a high-sugar diet seems to increase heart rate, promote 
insulin resistance and obesity. In this study, SHRs receiving 
sugar solution also possess an increment in heart rate at 1 
h post oral administration. Though the increment is not 
significant, the increment pattern also showed in another 
study that reported after 0.5-2 h of oral administration 
of sugar solution (sucrose, fructose and glucose), there 
was a significant increase in HR shown by healthy human 
subjects (Kumolosasi et al. 2016). 
CONCLUSION
Durian fruit possess an acute effect on the BP of the 
hypertensive rats by altering the SBP and DBP but heart 
rate was unaffected. High dose administration of durian 
(52 g/kg) led to a significant elevation of SBP and DBP 
after 1 h on the first day of consumption. Meanwhile, low 
dose administration of durian (26 g/kg) appeared to show 
insignificant reduction in SBP and DBP. Tolerance to the 
durian fruit was developed after three to seven days of oral 
administration. The low dose consumption of durian fruit 
did not affect BP and HR, however the caution is necessary 
if taking a high dose of durian in hypertensive subjects. 
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